NEU 3.50% $14.05 neuren pharmaceuticals limited

Evans partners report on Neu, page-38

  1. 2,844 Posts.
    lightbulb Created with Sketch. 600
    I keep asking myself, in whose interest is it for the SP to be held / manipulated to such an artificially low figure, roughly half of what the analysts who cover the company value it at.

    The only answer I can come up with is Acadia.

    When the inevitable t/o offer lobs, it is going to be based on the SP of the day, not on Bell Potter or Evans and Partners predictions.

    Its a bit like an auction with only one bidder currently. We desperately need a third party to at least get us back in the realms of fair value.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.